NF2 Archives - InventUM | University of Miami Miller School of Medicine

Clinical Trials

Miller School Selected for National NF2 Tumor Clinical Trial

A University of Miami Miller School of Medicine researcher is hoping an innovative multicenter clinical trial will lead to new therapies for neurofibromatosis type 2 (NF2), a devastating disease causing multiple types of tumors…

Jun. 02 2022 | Share

International Study Shows Low Incidence of COVID Vaccine-Related Myocarditis, Higher Risk from Virus

Third Dose of COVID-19 Vaccine Offers Needed Boost in Protection for Cirrhosis Patients

Miller School Researchers Find Clues for Potential ‘Long COVID’ Therapies

$3 Million Grant Awarded to Study Links between COVID and HIV

UHealth Celebrates Opening of Second One Medical Clinic in Miami-Dade County

Dr. M. Usman Shahid Joins the Department of Interventional Radiology

Fall 2022 University of Miami Medicine Magazine Now Available

Dr. David DQ Zhang, M.D., Joins the Division of Colon and Rectal Surgery

Studying Disparities in Care for Pelvic Floor Disorders

Powerful AI Algorithm Provides New Insights into Deadly Glioblastoma and Other Cancers

Dr. Richard Epstein Receives the J.S. Gravenstein Award from the Society for Technology in Anesthesia

Sylvester’s Myeloma Research Institute Sheds New Light on Therapy-Related Myeloid Cancers

Studying Disparities in Care for Pelvic Floor Disorders

Health Data Field Fuels New Department at Miller School of Medicine

Educating the Educators

Women in Academic Medicine Group Celebrates Female Faculty

NF2

Miller School Selected for National NF2 Tumor Clinical Trial